↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$539KSold on the market
1Companies
Sep 9, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202617:54 | Sep 8, 2026 | PCVXVaxcyte, Inc. | PRESIDENT AND CFO | F · Tax | $60.36 | −7,155 | 95,316 | -7% | $432K | ||
| Sep 2, 202619:56 | Sep 2, 2026from Aug 31, 2026 | PCVXVaxcyte, Inc. | PRESIDENT AND CFO | F · Tax | $61.18 | −2,705 | 102,471 | -3% | $166K | ||
| Aug 5, 202616:58 | Aug 3, 2026 | PCVXVaxcyte, Inc. | PRESIDENT AND CFO | S · Sell10b5-1 | $53.89 | −10,000 | 105,176 | -9% | −$539K | ||
| Aug 5, 202616:58 | Aug 3, 2026 | PCVXVaxcyte, Inc. | PRESIDENT AND CFO | M · Exercise10b5-1 | $5.35 | +10,000 | 115,176 | +10% | $54K |